Washington, D.C. and Orange County, Calif. (March 10,
2011) – Danaher Corporation (NYSE:DHR) and Beckman
Coulter, Inc. (NYSE: BEC) announced that they have received
notification of early termination of the waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
applicable to the tender offer for all of the outstanding shares of
common stock of Beckman Coulter at a price of $83.50 per share. As
previously announced, Danaher's tender offer for Beckman Coulter is
currently scheduled to expire at 12:00 midnight, New York City
time, at the end of Wednesday, March 23, 2011, unless the offer is
extended. The offer remains subject to customary conditions,
including receipt of other regulatory approvals. The transaction is
anticipated to close in the second quarter of 2011.
About Danaher
Danaher Corporation is a diversified technology leader
that designs, manufactures, and markets innovative products and
services to professional, medical, industrial, and commercial
customers. Its portfolio of premier brands is among the most highly
recognized in each of the markets it serves. Driven by a foundation
provided by the Danaher Business System, Danaher's 48,000
associates serve customers in more than 125 countries and generated
$13.2 billion of revenue in 2010. For more information please visit
Danaher's website: www.danaher.com.
About Beckman Coulter
Beckman Coulter, Inc., based in Orange County, California,
develops, manufactures and markets products that simplify, automate
and innovate complex biomedical tests. More than 275,000
Beckman Coulter systems operate in laboratories around the world,
supplying critical information for improving patient health and
reducing the cost of care. Recurring revenue, consisting of
consumable supplies (including reagent test kits), service and
operating-type lease payments, represent about 80% of the company's
2010 revenue of $3.7 billion. For more information, visit www.beckmancoulter.com.
Notice to Investors
This announcement is neither an offer to purchase nor a
solicitation of an offer to sell securities. The tender offer is
being made pursuant to a tender offer statement on Schedule TO
filed by Danaher with the SEC on February 15, 2011, as amended
through the date of this release. Beckman Coulter has filed a
solicitation/recommendation statement on Schedule 14D-9 with
respect to the tender offer on February 15, 2011, as amended
through the date of this release. The tender offer
statement (including an offer to purchase, a related letter of
transmittal and other tender offer documents) and the
solicitation/recommendation statement contain important information
that should be read carefully before making any decision to tender
securities in the tender offer. Beckman Coulter
stockholders may obtain a free copy of these materials (and all
other tender offer documents filed with the SEC) on the SEC's
website: www.sec.gov. The Schedule TO
(including the offer to purchase and related materials, and the
Schedule 14D-9, including the solicitation/recommendation
statement), may also be obtained for free by contacting Okapi
Partners LLC, the information agent for the tender offer, at (877)
274-8654.
Forward Looking Statements
Statements in this release that are not strictly
historical, including statements regarding the proposed
acquisition, the expected timetable for receiving regulatory
approvals and completing the transaction, and any other statements
regarding events or developments that we believe or anticipate will
or may occur in the future, may be "forward-looking" statements
within the meaning of the federal securities laws, and involve a
number of risks and uncertainties. There are a number of important
factors that could cause actual events to differ materially from
those suggested or indicated by such forward-looking statements and
you should not place undue reliance on any such forward-looking
statements. These factors include risks and uncertainties related
to, among other things: general economic conditions and conditions
affecting the industries in which Danaher and Beckman Coulter
operate; the uncertainty of regulatory approvals; the parties'
ability to satisfy the tender offer and merger agreement conditions
and consummate the transaction; and Beckman Coulter's performance
and maintenance of important business relationships. Additional
information regarding the factors that may cause actual results to
differ materially from these forward-looking statements is
available in Danaher's SEC filings, including Danaher's Annual
Report on Form 10-K for the year ended December 31, 2010, as well
as Beckman Coulter's SEC filings, including Beckman Coulter's
Annual Report on Form 10-K for the year ended December 31, 2010.
These forward-looking statements speak only as of the date of this
release and neither Danaher nor Beckman Coulter assumes any
obligation to update or revise any forward-looking statement,
whether as a result of new information, future events and
developments or otherwise, except as required by law.
Contacts
Danaher contact:
Matt R. McGrew
Vice President, Investor Relations
Danaher Corporation
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, D.C. 20037
Telephone: (202) 828-0850
Fax: (202) 419-7676
Beckman contact:
Cynthia Skoglund
Investor Relations Officer
Beckman Coulter, Inc.
250 S. Kraemer Blvd.
Brea, California 92821
Telephone: (714) 961-6320
Fax: (714) 961-4134
SOURCE